Back to discover
Disease

Immune System Diseases

Late-stage therapeutic developmentEmerging researchCooling momentum
20
Publications
20
Clinical trials
4
Related conditions
2
Related proteins
2025
Latest publication
Current focus
Q9nzq7 biologyTherapeutic developmentGenetics & risk factorsInflammation & immunityMetabolic & lifestyle factors
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this disease.

Molecular Insight into the Role of Vitamin D in Immune-Mediated Inflammatory Diseases.

Research2025-05-16International journal of molecular sciences

piRNA associates with immune diseases.

Research2024-06-28Cell communication and signaling : CCS

Antibody Cross-Reactivity in Auto-Immune Diseases.

Research2023-09-02International journal of molecular sciences

What's happening now

An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.

Major developments
Upcoming trial readoutHigh impact
Results expected Q2 20272026-07-02
Upcoming trial readoutHigh impact
Results expected Q4 20312026-06-30

Clinical trials

13 sponsors · 0 new · 0 completed in the last 12 months (net +0)

The current development programme across all trial phases.

Clinical programme
20
All trials
6
Active
2
Late-stage
6
Completed
Recently completed

Research activity

20 papers

Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.

Publications over time
20042025
Most influential

Of mice and not men: differences between mouse and human immunology.

Journal of immunology (Baltimore, Md. : 1950) · 2004 · 2,773 cites

Cytokine release syndrome.

Journal for immunotherapy of cancer · 2018 · 1,156 cites

Altered macrophage differentiation and immune dysfunction in tumor development.

The Journal of clinical investigation · 2007 · 935 cites

Th17 cells in human disease.

Immunological reviews · 2008 · 867 cites
Recent publications
Major themes8
  • Immune System Diseases9
  • Autoimmune Diseases2
  • Brain Neoplasms1
  • Carcinoma, Renal Cell1
  • Databases, Pharmaceutical1
  • Disease Susceptibility1
  • Gastrointestinal Microbiome1
  • Gene Expression1
Leading journals6
  • International journal of molecular sciences3
  • Frontiers in immunology2
  • Journal for immunotherapy of cancer2
  • Bone marrow transplantation1
  • Cell communication and signaling : CCS1
  • Environmental health and preventive medicine1
Leading researchers8
  • Franco JL2
  • Puel A2
  • Su HC2
  • Abel L1
  • Abolhassani H1
  • Abushahin L1
  • Adeniran A1
  • Aiuti A1
Affiliations (unnormalised)6
  • Brigham and Women's Hospital4
  • Harvard Medical School2
  • IRCCS San Raffaele Scientific Institute2
  • Laboratory of Human Genetics of Infectious Diseases2
  • Sorbonne University2
  • Allen Institute for Immunology1

Disease biology

2 matches

Key proteins & gene products studied in this disease. Number shows shared papers.

Related conditions

4 matches

Diseases frequently studied alongside this one. Number shows shared papers.

Disease profile

A grounded synthesis of the condition — overview, causes, mechanism, risk factors and current standard of care.

Overview

Immune system diseases are disorders caused by abnormal or absent immunologic mechanisms. They can involve humoral immunity, cell-mediated immunity, or both, and the literature frames them as a broad group of immune-mediated conditions rather than a single disease entity.

Causes

The grounding supports immune dysregulation as the central cause, including abnormal or absent humoral and/or cell-mediated immune mechanisms. It also links immune-mediated disease to autoimmunity and to dysbiosis-related immune disturbance, but does not support a single unified aetiology for the category as a whole.

Pathophysiology

The biological basis is failure of normal immune function, with downstream abnormalities in cytokine signaling, T-cell subset balance, and costimulatory pathways. The supplied literature also points to immune dysfunction involving Th17 cells, regulatory and helper T-cell subsets, and altered interactions between immune cells and tissue targets.

Risk factors

The grounding does not support specific risk factors for immune system diseases as a category. It does indicate that gut microbiota dysbiosis, diet, and antibiotics can contribute to immune dysregulation in some immune-mediated contexts, but not as universal risk factors.

Current standard of care

The supplied material supports treatment at the level of broad modalities such as drug therapy and therapy, but does not define a single standard regimen for this category. It also references immunotherapy-related approaches in the broader immune-disease literature, including immune checkpoint inhibition and T-cell engaging therapies, but these are not presented as standard care for immune system diseases overall.

AI-generated summary grounded in MeSH and 6 peer-reviewed sources. Informational only — not medical advice. Generated 2026-07-07.

Reference

Authoritative identity, definition & identifiers.

Defined in MeSH

Disorders caused by abnormal or absent immunologic mechanisms, whether humoral, cell-mediated, or both.

References & data sources
  • Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
  • Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
  • Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
  • Related entities are derived from literature co-mention (studied together) — associative, not causal.